FWBI - First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico | Benzinga
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the Sequire Investor Summit 2024, which is planned for January 23-25, 2024, at Condado Vanderbilt Hotel in San Juan, Puerto Rico.
Details of the event are as follows:
| Event: |
| Sequire Investor Summit 2024 |
| Date: |
| January 23-25, 2024 |
| Presentation |
| January 24, 10:30 AM AST, Track 3 (Salon Azul) |
| Location: |